Basic info
Industry
pharmaceutical manufacturing
Sectors
stroke risk reduction
Inc. medicines approved in the U.S. include therapies for metastatic breast and gastric cancer
Daiichi Sankyo
Wellness
Inc. is a member of the Daiichi Sankyo Group and is focused on the development of oncology therapies and specialty medicines. Daiichi Sankyo
tenosynovial giant cell tumor
Health Care
acute coronary syndrome
thrombosis
metastatic melanoma
Therapeutics
IV iron therapy. PP-US-NP-1500 6/21
dyslipidemia
diabetes
hypertension
Date founded
2010